China Universal Asset Management »

Tarsus Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $239k 6.6k 36.39
2023-12-31 $78k 3.8k 20.35
2023-09-30 $15k 828 18.12
2023-06-30 $6.0k 352 17.05
2023-03-31 $5.0k 362 13.81
2022-12-31 $4.0k 271 14.76

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Tarsus Pharmaceuticals

Cormorant Asset Management
Tang Capital Management
Cowen And Company
Frazier Life Sciences Management
Vanguard Group
Jennison Associates
Perceptive Advisors
Paradigm Biocapital Advisors
Polygon Management
Ikarian Capital
Vivo Capital
Dimensional Fund Advisors
Artisan Partners Limited Partnership
Nantahala Capital Management
Bank of America Corporation

View all funds holding Tarsus Pharmaceuticals